Skip to main content

Vaxart, Inc.

VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000072444

No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Vaxart, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of VXRT: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders141147+6
Shares37.4M42.7M+5.33M (+14.3%)
Value$297.5M$267.9M−$29.6M (−10.0%)

New holders (29)

Institutions that held Vaxart, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to VXRT in Q4 2021
InstitutionSharesValue% of portfolio
National Bank of Canada316,201$1.98M0.01%
Ergoteles LLC145,581$913.0K0.04%
Alps Advisors Inc144,972$909.0K0.01%
Jump Financial, LLC131,458$825.0K0.05%
Dimensional Fund Advisors LP119,788$751.0K0.00%
Corient Capital Partners, LLC90,408$567.0K0.04%
Two Sigma Advisers, LP43,200$271.0K0.00%
Ensign Peak Advisors, Inc39,240$246.0K0.00%
Cambridge Investment Research Advisors, Inc.26,318$165.0K0.00%
Allspring Global Investments Holdings, LLC24,346$152.0K0.00%
Walleye Trading LLC18,646$117.0K0.00%
Engineers Gate Manager LP17,362$109.0K0.00%
Bank of Montreal15,127$98.0K0.00%
Manteio Capital LLC14,378$90.0K0.12%
Fi3 FINANCIAL ADVISORS, LLC12,000$75.0K0.05%
MML Investors Services, LLC11,500$72.0K0.00%
Moors & Cabot, Inc.10,000$63.0K0.00%
Parallax Volatility Advisers, L.P.5,621$35.0K0.00%
Zullo Investment Group, Inc.4,000$25.0K0.01%
Cornerstone Advisory, LLC3,000$19.0K0.00%
CoreCap Advisors, LLC1,004$6.00K0.00%
CWM, LLC400$3.00K0.00%
IFP Advisors, Inc460$3.00K0.00%
Northwestern Mutual Wealth Management Co350$2.00K0.00%
Umb Bank N A100$1.00K0.00%
TD Waterhouse Canada Inc.35$2910.00%
Bogart Wealth, LLC30$00.00%
Concord Wealth Partners75$00.00%
Confluence Wealth Services, Inc.3$00.00%

Sold out (23)

Institutions that held Vaxart, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.